IS3 - Invited Science: Aging and Dementia
Event Time: | Thursday May 9, 2019 3:30 pm to 5:30 pm |
Topic(s): | Aging, Dementia, Cognitive, and Behavioral Neurology |
Director(s): | Karen Marder MD, MPH, FAAN, Heather Snyder PhD |
Description: | In collaboration with the Alzheimer's Association and the Alzheimer's Association International Conference (AAIC),this session will highlight cutting edge science and hot topics in Alzheimer's disease and related dementia. Here we highlight basic, clinical and translational science as they evolve toward a more complete understanding of dementia, emerging trends and impact on global health. |
Completion Message: | |
CME Credits: | 2 |
Core Competencies: |
Start/End Time | Title | Faculty |
---|---|---|
3:30 PM - 3:35 PM | Introduction | Karen S. Marder MD, MPH, FAAN, Heather M. Snyder PhD |
3:35 PM - 3:55 PM | A Randomized Trial of Intensive Versus Standard Systolic Blood Pressure Control on Brain Structure: Results from SPRINT MIND MRI | Ilya Nasrallah MD, PhD |
3:55 PM - 4:15 PM | Challenges in Using CSF Biomarkers for Operationalizing the NIA-AA AD Research Framework | Michelle M. Mielke PhD |
4:15 PM - 4:35 PM | Medical Management – Recommendations From the Dementia Care Practice Recommendations | Mary Guerriero Austrom PhD |
4:35 PM - 4:55 PM | The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study - Report of Screening Data Results | Rema Raman PhD |
4:55 PM - 5:15 PM | US Perspective on Clinical Amyloid Imaging | Ronald C. Petersen PhD, MD, FAAN |
5:15 PM - 5:30 PM | Questions and Answers | Mary Guerriero Austrom PhD, Michelle M. Mielke PhD, Ilya Nasrallah MD, PhD, Ronald C. Petersen PhD, MD, FAAN, Rema Raman PhD |
Speaker | Disclosure |
---|---|
Mary Guerriero Austrom, PhD | Dr. Austrom has nothing to disclose. |
Karen S. Marder, MD, MPH, FAAN | Dr. Marder has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Voyager Therapeutics. Dr. Marder has received personal compensation in an editorial capacity for Springer. Dr. Marder has received research support from TEVA, Azevan, Vaccinex, and Roche. |
Michelle M. Mielke, PhD | Dr. Mielke has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Lysosomal Therapeutics, Inc. Dr. Mielke has received research support from Biogen, Roche, and Lundbeck. |
Ilya Nasrallah, MD, PhD | Dr. Nasrallah has received research support from Avid Radiopharmaceuticals. |
Ronald C. Petersen, PhD, MD, FAAN | Dr. Petersen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche Inc., Merck Inc., Genentech Inc., Biogen Inc., Eisai Inc., and GE Healthcare. Dr. Petersen has received personal compensation in an editorial capacity for UpToDate. |
Rema Raman, PhD | Dr. Raman has nothing to disclose. |
Heather M. Snyder, PhD | Dr. Snyder has nothing to disclose. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C1 -
What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders
Daniel Kaufer MD, FAAN |
9:30 AM-11:30 AM |
C13 -
Clinicopathological Correlation Session in Dementia
David Irwin MD |
1:30 PM-3:30 PM |
C32 -
The Neurology of Social Behavior
Bradford Dickerson MD, FAAN |
4:15 PM-5:30 PM |
Hot Topics Plenary Session
Eric Klawiter MD, FAAN |
7:00 AM-9:00 AM |
---|
C37 -
Chronic Traumatic Encephalopathy: Update
Andrew Budson MD |
11:30 AM-6:30 PM |
P1 -
Poster Session 1
|
1:00 PM-3:00 PM |
C60 -
Assessment of Rapidly Progressive Dementias I: Prion and Non-prion Neurodegenerative Diseases
Michael Geschwind MD, PhD, FAAN |
3:30 PM-5:30 PM |
C76 -
Assessment of Rapidly Progressive Dementias II: Infections and Autoimmune Mediated Conditions
Michael Geschwind MD, PhD, FAAN |
C67 -
Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
S9 -
Aging and Dementia: Clinical Trials and Novel Therapies
|
7:00 AM-9:00 AM |
---|
C78 -
Young Onset and Atypical Alzheimer's Dementia
Jonathan Graff-Radford MD |
C85 -
Severe TBI: From ICU to Rehabilitation
Susanne Muehlschlegel MD, MPH, FAAN |
8:00 AM-8:45 AM |
Physical Exercise and Cognitive Training in Neurology-Application in Aging & Neurodegenerative Disease
Ergun Uc MD |
9:15 AM-12:00 PM |
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
11:30 AM-6:30 PM |
P2 -
Poster Session 2
|
1:00 PM-3:00 PM |
C88 -
Mild Cognitive Impairment: Implications for Clinicians
Ronald Petersen PhD, MD, FAAN |
S13 -
Behavioral and Cognitive Neurology: Behavioral Neurology, Aging, and Dementia
|
3:30 PM-5:30 PM |
C106 -
Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment
David Knopman MD, FAAN |
Presentation of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
|
5:00 PM-5:45 PM |
Defining, Evaluating, and Promoting Healthy Cognitive Aging
Kirk Daffner MD, FAAN |
7:00 AM-9:00 AM |
---|
C122 -
Neurocognitive Assessment for Neurologists
Mario Mendez MD, PhD, FAAN |
9:15 AM-11:30 AM |
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
11:30 AM-6:30 PM |
P3 -
Poster Session 3
|
1:00 PM-3:00 PM |
C132 -
Frontotemporal Dementias
Elizabeth Finger MD, FAAN |
3:30 PM-5:30 PM |
C151 -
Lewy Body Dementias
Karen Marder MD, MPH, FAAN |
7:00 AM-9:00 AM |
---|
C166 -
Neuroimaging Biomarkers Across the Dementia Spectrum
Liana Apostolova MD, FAAN |
11:30 AM-6:30 PM |
P4 -
Poster Session 4
|
1:00 PM-3:00 PM |
C176 -
Behavioral Neurology I: Network Anatomy of Behavior and Language
Maria Gorno Tempini MD, PhD |
S34 -
Aging and Dementia: Risk Factors, Biomarkers, and Neuropathology
|
3:30 PM-5:30 PM |
C193 -
Behavioral Neurology II: Memory and Attention
Maria Gorno Tempini MD, PhD |
5:00 PM-5:45 PM |
Case Studies: When to Refer Patients for Cognitive Behavioral or Mindfulness-based Psychotherapies: Expanding the Neurologist's Toolkit
David Perez MD, Aneeta Saxena MD, Gaston Baslet MD |
7:00 AM-9:00 AM |
---|
C206 -
Vascular Cognitive Impairment and Dementia: Current Status and Future
Larry Goldstein MD, FAAN, FAHA |
11:30 AM-6:30 PM |
P5 -
Poster Session 5
|
11:45 AM-12:30 PM |
How Your Social Life Might Be Helping (or Harming) Your Brain
Joel Salinas MD |
1:00 PM-3:00 PM |
C216 -
Higher Cortical Visual Disorders: Case-based Review
Sashank Prasad MD |
3:30 PM-5:30 PM |
5:00 PM-5:45 PM |
Influence of a Comprehensive Lifestyle Intervention on Prevention of Dementia
Dean Sherzai MD, MAS, PhD, Ayesha Sherzai MD |
7:00 PM-10:00 PM |
C242 -
Case Studies: Dementia
Gregory Day MD, MSc |
9:15 AM-11:30 AM |
---|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
11:45 AM-12:45 PM |
Friday Grand Finale: Neuroimaging
|
1:00 PM-3:00 PM |
C252 -
Update in Aging and Dementia
Gil Rabinovici MD |
3:30 PM-4:30 PM |
C255 -
Education Blitz: Normal Pressure Hydrocephalus
Neill Graff-Radford MD, FAAN |